JUN 30, 2021 7:00 AM PDT

A Deep Learning Tool for Faster, Better Heart Disease Diagnoses

WRITTEN BY: Tara Fernandez

A new deep learning tool could help slash the time it takes to interpret cardiology scans to diagnose obstructive coronary artery disease by 75 percent. The study, featured in the European Journal of Radiology, describes how this new technology, powered by artificial intelligence (AI) can not only accelerate processing times but also assist radiologists in identifying potential problem areas in the patients’ major arteries.

In obstructive coronary arterial disease, the blood vessels that supply the heart gradually narrow, and in severe classes, can even close completely. This happens as a result of the accumulation of plaque in a process called atherosclerosis.

Checking for obstructions and blockages in coronary scans can be challenging—radiologists require specialized training and extensive experience in order to be able to interpret these scans correctly.

According to Chun Yu Liu, lead author of the study, AI can complement scan interpretation by trained medical staff, speeding it up and improving accuracy.

The new diagnostic platform was built on scan data from 165 patients, with a threshold of at least 50 percent of luminal stenosis as a reference level for a positive diagnosis.

The team’s analysis revealed that the AI system proved to be reliable, diagnosing coronary artery disease with 90.5 percent sensitivity and 82.3 percent specificity. Most promisingly, it sped up processing times from 8.5 to 3.7 minutes.

Coronary artery calcification, or the buildup of calcium deposits on the inner walls of arteries, didn’t affect the software’s performance, and similarly, it was not impacted by differences in input image quality.

“Image quality and calcification burden did not negatively affect the diagnostic performance of AI,” explained Liu. “Thus, AI may be an efficient tool for the diagnosis of coronary artery stenosis.”

 

 

Sources: Diagnostic Imaging, European Journal of Radiology.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 13, 2021
Cardiology
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
APR 13, 2021
Can a Ketosis Metabolite Act as a Biomarker for Cardiovascular Diseases?
Quick and reliable diagnostics are the key to controlling many diseases, including cardiovascular disease. Biomarkers ar ...
APR 12, 2021
Microbiology
New Lyme Test Can ID The DIsease Early
APR 12, 2021
New Lyme Test Can ID The DIsease Early
Lyme disease is a disease that is caused by four main species of bacteria, including Borrelia burgdorferi, which ar ...
APR 27, 2021
Cardiology
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
APR 27, 2021
New miRNAs Might Help Diagnose Severe Dilated Cardiomyopathy
The heart is one of the most reliable parts of the body. It pumps day and night, delivering fresh oxygen and nutrients t ...
AUG 03, 2021
Drug Discovery & Development
A pediatric-friendly drug to combat snail fever
AUG 03, 2021
A pediatric-friendly drug to combat snail fever
           Schistosomiasis, also known as Bilharzia or snail fever, is a disease  ...
AUG 17, 2021
Clinical & Molecular DX
Sleep Apnea Doubles the Risk of Sudden Death
AUG 17, 2021
Sleep Apnea Doubles the Risk of Sudden Death
Obstructive sleep apnea, or OSA, is the most commonly reported sleep disorder, with loud snoring being one of the tell-t ...
AUG 31, 2021
Clinical & Molecular DX
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
AUG 31, 2021
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
Alzheimer's is a neurodegenerative disease that affects over 26 million worldwide and is associated with memory prob ...
Loading Comments...